MARK2 and polycystic ovary syndrome: Various signaling pathways, including the phosphatidylinositol 3‐kinase (PI3K)/serine/threonine kinase (AKT) and MAPK/ERK1/2 pathways, are implicated in the pathogenesis of PCOS [38].